Company profile for Lophora

NEW Drugs in Dev.: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Lophora is a drug-development start-up focusing on central nervous system diseases including treatment-resistant depression. Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate through funding granted by the BioInovation Institute (Novo Nordisk Foundation) and plan to begin first-in-human trials by 2022. The company has identified and patented a new class of proprietary ligands ...
Lophora is a drug-development start-up focusing on central nervous system diseases including treatment-resistant depression. Founded in 2018 Lophora has successfully finished initial characterization of its lead-candidate through funding granted by the BioInovation Institute (Novo Nordisk Foundation) and plan to begin first-in-human trials by 2022. The company has identified and patented a new class of proprietary ligands that has a similar pharmacological profile as psilocybin, which has shown promising clinical results in the treatment of depression.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Denmark
Address
Address
Ole Maaløes Vej 3, Copenhagen, Capital Region 2200
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty